-
-
-
-
-
-
-
Clearmind submits psychedelic therapy recommendations to FDA
-
-
-
-
-
-
-
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
-
-
-
-
-
-
-
Clearmind files U.S. patent for MDMA-PEA combination to treat PTSD
-
-
-
-
-
-
-
Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company
-
-
-
-
-
-
-
FDA issues psychedelic therapy guidance as Clearmind notes federal push
-
-
-
-
-
-
-
Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative
-
-
-
-
-
-
-
Clearmind Medicine receives U.S. patent for binge behavior compound
-
1,202,949 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


